SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $RHHBY–Genentech to present new data at ESMO across oncology portfolio including positive Phase III Krascendo 1 data in lung cancer
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $RHHBY–Genentech to present new data at ESMO across oncology portfolio including positive Phase III Krascendo 1 data in lung cancer